Search

Author/Creator Mahmood, Adnan

1. 1079. Casirivimab and Imdevimab (CAS + IMD) Antibody Combination for the Treatment of Immunocomprised Hospitalized Patients with COVID-19. (15th December 2022)

Authors:
Somersan-Karakaya, Selin; Mylonakis, Eleftherios; Oviedo-Orta, Ernesto; O'Brien, Meagan P; Casullo, Veronica Mas; Mou, Jenni; Xiao, Jing; Bhore, Rafia; Mahmood, Adnan; Hooper, Andrea T; Hussein, Mohamed; Ali, Shazia; Forleo-Neto, Eduardo; Herman, Gary A; Hirshberg, Boaz; Weinreich, David M
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022)

Authors:
Herman, Gary A; O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Musser, Bret J; Davis, John D; Turner, Kenneth C; Mahmood,...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 10(2022)
Page Start:
1444
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial. (26th February 2022)

Authors:
Sivapalasingam, Sumathi; Lederer, David J; Bhore, Rafia; Hajizadeh, Negin; Criner, Gerard; Hosain, Romana; Mahmood, Adnan; Giannelou, Angeliki; Somersan-Karakaya, Selin; O'Brien, Meagan P; Boyapati, Anita; Parrino, Janie; Musser, Bret J; Labriola-Tompkins, Emily; Ramesh, Divya; Purcell, Lisa A; G...
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 1(2022)
Page Start:
e380
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen. (4th December 2021)

Authors:
Mylonakis, Eleftherios; Somersan-Karakaya, Selin; Sivapalasingam, Sumathi; Ali, Shazia; Sun, Yiping; Bhore, Rafia; Mei, Jingning; Miller, Jutta; Cupelli, Lisa; Hooper, Andrea T; Hamilton, Jennifer D; Pan, Cynthia; Pham, Viet; Zhao, Yuming; Hosain, Romana; Mahmood, Adnan; Davis, John D; Turner, Ke...
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S809
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Poster 485 Safety and Tolerability of AbobotulinumtoxinA (Dysport) in Children (2‐17 Years) with Lower Limb Spasticity Due to Cerebral Palsy: A Pooled Analysis of 8 Clinical Trials. Issue 9 (24th September 2016)

Authors:
Matthews, Dennis; Camba, George C.; Pascual‐Pascual, Ignacio; Tilton, Ann H.; Gormley, Mark; Mahmood, Adnan; Picaut, Philippe; Snyder, Daniel; Delgado, Mauricio R.
Journal:
PM&R
Issue:
Volume 8:Issue 9(2016)Supplement
Page Start:
S318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19. (September 2022)

Authors:
Isa, Flonza; Forleo-Neto, Eduardo; Meyer, Jonathan; Zheng, Wenjun; Rasmussen, Scott; Armas, Danielle; Oshita, Masaru; Brinson, Cynthia; Folkerth, Steven; Faria, Lori; Heirman, Ingeborg; Sarkar, Neena; Musser, Bret J.; Bansal, Shikha; O'Brien, Meagan P.; Turner, Kenneth C.; Ganguly, Samit; Mahmood...
Journal:
International journal of infectious diseases
Issue:
Volume 122(2022)
Page Start:
585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗